{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:56:20Z","timestamp":1793814980305,"version":"4.6.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.thromres.2011.02.006","type":"journal-article","created":{"date-parts":[[2011,4,14]],"date-time":"2011-04-14T12:07:51Z","timestamp":1302782871000},"page":"77-85","source":"Crossref","is-referenced-by-count":168,"title":["The association between antiphospholipid antibodies and placenta mediated complications: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"128","author":[{"given":"Karim","family":"Abou-Nassar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Rodger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2011.02.006_bb0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/jaut.2000.0409","article-title":"Epidemiology of the antiphospholipid antibody syndrome","volume":"15","author":"Petri","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.thromres.2011.02.006_bb0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005792-199303000-00005","article-title":"Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1, 000 patients","volume":"72","author":"Cervera","year":"1993","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.thromres.2011.02.006_bb0015","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-112-9-682","article-title":"Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance","volume":"112","author":"Love","year":"1990","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.thromres.2011.02.006_bb0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0002-9378(89)90522-X","article-title":"The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population","volume":"161","author":"Lockwood","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.thromres.2011.02.006_bb0025","doi-asserted-by":"crossref","first-page":"470","DOI":"10.7326\/0003-4819-120-6-199403150-00004","article-title":"Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study","volume":"120","author":"Lynch","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2011.02.006_bb0030","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0029-7844(95)80015-8","article-title":"Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy","volume":"86","author":"Yasuda","year":"1995","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.thromres.2011.02.006_bb0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s004040050007","article-title":"Anticardiolipin antibodies levels in healthy pregnant and non-pregnant woman","volume":"263","author":"Tsapanos","year":"2000","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.thromres.2011.02.006_bb0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0301-2115(98)00233-4","article-title":"A prospective study on the occurrence of autoantibodies in low-risk pregnancies","volume":"83","author":"Matthiesen","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.thromres.2011.02.006_bb0045","first-page":"486","article-title":"The anticardiolipin syndrome","volume":"13","author":"Hughes","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1016\/j.thromres.2011.02.006_bb0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005792-198911000-00003","article-title":"Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective analysis of 500 consecutive patients","volume":"68","author":"Alarc\u00f3n-Segovia","year":"1989","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.thromres.2011.02.006_bb0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review","volume":"132","author":"Robertson","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2011.02.006_bb0060","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International conssensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.thromres.2011.02.006_bb0065","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.thromres.2011.02.006_bb0070","first-page":"2214","article-title":"Association Between Antiphospholipid Antibodies and Recurrent Fetal Loss in Women Without Autoimmune Disease: A Metaanalysis","volume":"33","author":"Opatrny","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.thromres.2011.02.006_bb0075","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1111\/j.1538-7836.2004.00910.x","article-title":"Proposals for the measurement of anti-beta2-glycoprotein 1 antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies","volume":"2","author":"Reber","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.thromres.2011.02.006_bb0080","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1542\/peds.108.2.e35","article-title":"A new and improved population-based Canadian reference for birth weight for gestational age","volume":"108","author":"Kramer","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.thromres.2011.02.006_bb0085","author":"Wells"},{"key":"10.1016\/j.thromres.2011.02.006_bb0090","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"5pt 1","key":"10.1016\/j.thromres.2011.02.006_bb0095","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0029-7844(01)01190-5","article-title":"Postnatal screening for thrombophilia in women with severe pregnancy complications","volume":"97","author":"Alfirevic","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.thromres.2011.02.006_bb0100","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/00016349409006249","article-title":"Antiphospholipid antibodies and risk of intrauterine fetal death","volume":"73","author":"Bocciolone","year":"1994","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.thromres.2011.02.006_bb0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0029-7844(00)01099-1","article-title":"Antiphospholipid antibodies and preeclampsia: a case-control study","volume":"97","author":"Dreyfus","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.thromres.2011.02.006_bb0110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000009930","article-title":"Antiphospholipid antibodies in eclamptic women","volume":"45","author":"Kaleli","year":"1998","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.thromres.2011.02.006_bb0115","first-page":"197","volume":"29","author":"Mello","year":"1999","journal-title":"Haemostasis"},{"key":"10.1016\/j.thromres.2011.02.006_bb0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0002-9378(91)90222-D","article-title":"The prevalence of autoantibodies during third-trimester pregnancy complicated by hypertension or idiopathic fetal growth restriction","volume":"165","author":"Milliez","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.thromres.2011.02.006_bb0125","first-page":"105","article-title":"The association of antiphospholipid antibodies with severe early-onset pre-eclampsia","volume":"85","author":"Moodley","year":"1995","journal-title":"S Afr Med J"},{"key":"10.1016\/j.thromres.2011.02.006_bb0130","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1471-0528.1993.tb15105.x","article-title":"Antiphospholipid antibodies in pregnancy: prevalence and clinical associations","volume":"100","author":"Pattison","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.thromres.2011.02.006_bb0135","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/00016349209006228","article-title":"Lupus anticoagulant and anticardiolipin antibodies in an obstetric population","volume":"71","author":"Rix","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10.1016\/j.thromres.2011.02.006_bb0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/10641959809072240","article-title":"Preeclampsia and fetal growth retardation: is there an association with antiphospholipid antibodies?","volume":"17","author":"Schjetlein","year":"1998","journal-title":"Hypertens Pregnancy"},{"issue":"1","key":"10.1016\/j.thromres.2011.02.006_bb0145","first-page":"47","article-title":"Comparison of antiphospholipid antibodies between preeclamptsia and normal pregnant women","volume":"31","author":"Vahid","year":"2006","journal-title":"Iran J Med Sci"},{"issue":"3","key":"10.1016\/j.thromres.2011.02.006_bb0150","first-page":"126","article-title":"Lupus anticoagulant in Jamaican primipare and the clinical significance in asymptomatic patients","volume":"48","author":"Wharfe","year":"1999","journal-title":"West Indian Med J"},{"key":"10.1016\/j.thromres.2011.02.006_bb0155","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0897.1996.tb00143.x","article-title":"Antiphospholipid antibodies and patients with preeclampsia","volume":"36","author":"Allen","year":"1996","journal-title":"Am J Reprod Immunol"},{"issue":"5","key":"10.1016\/j.thromres.2011.02.006_bb0160","first-page":"825","article-title":"Antibodies to oxidized low density lipoproteins and cardiolipin in pre-eclampsia and eclampsia","volume":"184","author":"Bowen","year":"2002","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.thromres.2011.02.006_bb0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0301-2115(97)02736-X","volume":"73","author":"Faden","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.thromres.2011.02.006_bb0170","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/HUMREP\/11.3.509","article-title":"B2-Glycoprotein 1-dependant anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women","volume":"11","author":"Katano","year":"1996","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.thromres.2011.02.006_bb0175","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0029-7844(03)00477-0","article-title":"Anticardiolipin and anti-beta2-glycoprotein-I antibodies in preeclampsia","volume":"102","author":"Lee","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.thromres.2011.02.006_bb0180","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0002-9378(99)70507-7","article-title":"Anti-B2 Glycoprotein 1 antobodies and women with recurrent spontaneous abortions, unexplained fetal death, and antiphospholipid syndrome","volume":"181","author":"Lee","year":"1999","journal-title":"Am J Obstet Gynceol"},{"key":"10.1016\/j.thromres.2011.02.006_bb0185","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/096120339500400506","article-title":"Longitudinal measurement of anticardiolipin antibodies during normal pregnancy: a prospective study","volume":"4","author":"Lynch","year":"1995","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2011.02.006_bb0190","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1471-0528.1993.tb15319.x","article-title":"A prospective study of pregnancy outcome in women screened at a routine antenatal clinic for anticardiolipin antibodies","volume":"100","author":"Stuart","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.thromres.2011.02.006_bb0195","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0301-2115(96)02574-2","article-title":"Anticardiolipin antibodies in pregnancy induced hypertension","volume":"70","author":"Uncu","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.thromres.2011.02.006_bb0200","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0188-4409(02)00367-3","article-title":"Anticardiolipin and antibeta2-glycoprotein-I antibodies in hypertensive disorders of pregnancy","volume":"33","author":"Valdes-Macho","year":"2002","journal-title":"Arch Med Res"},{"issue":"5","key":"10.1016\/j.thromres.2011.02.006_bb0205","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0002-9378(99)70608-3","article-title":"High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia","volume":"180","author":"van Pampus","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.thromres.2011.02.006_bb0210","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1447-0756.1996.tb00979.x","article-title":"Anti-phospholipid antibodies in preeclampsia and their binding ability for placental villous lipid fractions","volume":"22","author":"Yamamoto","year":"1996","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.thromres.2011.02.006_bb0215","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000263951","article-title":"Poor pregnancy outcomes and anticardiolipin antibodies","volume":"9","author":"De Carolis","year":"1994","journal-title":"Fetal Diagn Ther"},{"issue":"2","key":"10.1016\/j.thromres.2011.02.006_bb0220","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejogrb.2007.05.014","article-title":"A comprehensive screening analysis of antiphospholipid antibodies in Indian women with fetal loss","volume":"137","author":"Vora","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.thromres.2011.02.006_bb0225","first-page":"S67","article-title":"Real world experience with antiphospholipid antibodies (aPL): How stable are aPL over time?","volume":"50","author":"Dereksen","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"6 Suppl","key":"10.1016\/j.thromres.2011.02.006_bb0230","doi-asserted-by":"crossref","first-page":"844S","DOI":"10.1378\/chest.08-0761","article-title":"Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Bates","year":"2008","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.thromres.2011.02.006_bb0235","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJM198703123161105","article-title":"Maternal mortality in Massachusetts. Trends and prevention","volume":"316","author":"Sachs","year":"1987","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.thromres.2011.02.006_bb0240","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1055\/s-0038-1657712","article-title":"Risk factors for pregnancyassociated venous thromboembolism","volume":"78","author":"McColl","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.02.006_bb0245","first-page":"715","article-title":"Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy","volume":"157","author":"Helewa","year":"1997","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.thromres.2011.02.006_bb0250","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-3476(97)70316-0","article-title":"Effects of intrauterine growth retardation in premature infants on early childhood growth","volume":"130","author":"Strauss","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.thromres.2011.02.006_bb0255","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/oxfordjournals.bmb.a011608","article-title":"Effects of the intrauterine environment on childhood growth","volume":"53","author":"Strauss","year":"1997","journal-title":"Br Med Bull"},{"issue":"1","key":"10.1016\/j.thromres.2011.02.006_bb0260","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-3476(98)70180-5","article-title":"Growth and development of term children born with low birth weight: effects of genetic and environmental factors","volume":"133","author":"Strauss","year":"1998","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.thromres.2011.02.006_bb0265","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/jama.283.5.625","article-title":"Adult functional outcome of those born small for gestational age: twenty-six-year followup of the 1970 British Birth Cohort","volume":"283","author":"Strauss","year":"2000","journal-title":"JAMA"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811000739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811000739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T03:30:42Z","timestamp":1592451042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384811000739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0049384811000739"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2011.02.006","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}